Cargando…

P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE

Detalles Bibliográficos
Autores principales:	L., SMART, C., SEGBEFIA, T., LATHAM, S., STUBER, K., AMISSAH-ARTHUR, A., LANE, Y., DEI-ADOMAKOH, R., WARE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Poster Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429746/ http://dx.doi.org/10.1097/01.HS9.0000873080.46800.92

Ejemplares similares

Prospective identification of variables as outcomes for treatment (PIVOT): study protocol for a randomised, placebo-controlled trial of hydroxyurea for Ghanaian children and adults with haemoglobin SC disease
por: Smart, Luke R., et al.
Publicado: (2023)

P-017: POINT-OF-CARE DIAGNOSTIC FOR QUANTIFICATION OF FOETAL HAEMOGLOBIN (HB F) LEVELS IN MONITORING HYDROXYUREA THERAPY FOR CHILDREN WITH SICKLE CELL DISEASE (SCD) IN GHANA
por: C., SEGBEFIA, et al.
Publicado: (2022)

Most adults with severe HbSC disease are not treated with hydroxyurea
por: Ghunney, William Kwesi, et al.
Publicado: (2023)

O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE
por: A., POWER-HAYS, et al.
Publicado: (2022)

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
por: POWER-HAYS, A., et al.
Publicado: (2022)

P-003: EVALUATION OF TREATMENT PATTERN, HEALTHCARE RESOURCE UTILIZATION AND COSTS OF ILLNESS FOR SICKLE CELL DISEASE IN GHANA: A PRIVATE MEDICAL INSURANCE CLAIMS DATABASE STUDY
por: Y., DEI-ADOMAKOH, et al.
Publicado: (2022)

S129: IMPLEMENTATION OF HYDROXYUREA THERAPY FOR SICKLE CELL DISEASE ON A LARGE SCALE IN GHANA
por: Ohene-Frempong, K, et al.
Publicado: (2022)

O-12: BUILDING LOCAL CAPACITY FOR HYDROXYUREA PHARMACOKINETICS AND PRECISION DOSING IN LOW-RESOURCE SETTINGS
por: L., SMART, et al.
Publicado: (2022)

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia
por: Rankine-Mullings, Angela E, et al.
Publicado: (2016)

P047: Fighting MRSA in an high endemic level hospital
por: Neves, I, et al.
Publicado: (2013)

O047 Sleep quality and fatigue in children and adolescents with multiple sclerosis
por: Tran, J, et al.
Publicado: (2021)

P047. Paroxysmal episodic hemicrania in a child. A complex differential diagnosis
por: Frusciante, Roberto, et al.
Publicado: (2015)

AB047. Clinic therapeutic effect of sigmoid orthotopic neobladder after radical cystectomy
por: Zhang, Jin, et al.
Publicado: (2016)

O047 Representations of Sleep in Social Media: A Tik Tok Case Study
por: Voggenreiter, A, et al.
Publicado: (2023)

P-002: MULTISPECTRAL IMAGING FOR MICROCHIP ELECTROPHORESIS ENABLES POINT-OF-CARE NEWBORN HEMOGLOBIN VARIANT SCREENING
por: R., AN, et al.
Publicado: (2022)

Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub‐Saharan Africa: Rationale and Design of the REACH Trial
por: McGann, Patrick T., et al.
Publicado: (2015)

O047. The sound-induced flash illusions reveal visual cortex hyperexcitability in cluster headache
por: Cosentino, Giuseppe, et al.
Publicado: (2015)

Stroke Avoidance for Children in REpública Dominicana (SACRED): Protocol for a Prospective Study of Stroke Risk and Hydroxyurea Treatment in Sickle Cell Anemia
por: Jeste, Neelum D, et al.
Publicado: (2017)

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings
por: Smart, Luke R., et al.
Publicado: (2023)

SAT-047 Disorders in Mice with Subclinical Hypothyroidism
por: Chen, Wenbin, et al.
Publicado: (2019)

P-075: HYDROXYUREA: EFFECTS ON TREATMENT OF CHILDREN WITH HEMOGLOBINOPATHY SC
por: A., CAMPOS, et al.
Publicado: (2022)

P-018: MILESTONES ALONG MY PERSONAL JOURNEY WITH HYDROXYUREA
por: A., SHAKIR
Publicado: (2022)

P047 Rehabilitation-led management of sleep disordered breathing: adapting a model of care for a rehabilitation centre in Australia
por: Graco, M, et al.
Publicado: (2022)

P047 Sleep and diet in older adults: what do we know and what do we need to find out?
por: Gupta, C, et al.
Publicado: (2021)

Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma
por: Reardon, D A, et al.
Publicado: (2009)

Association Between Selected Single Nucleotide Polymorphisms in Globin and Related Genes and Response to Hydroxyurea Therapy in Ghanaian Children with Sickle Cell Disease
por: Manu, Gloria Pokuaa, et al.
Publicado: (2022)

Hydroxyurea-Induced Interstitial Pneumonitis: A Rare Clinical Entity
por: Kamal, Palwasha, et al.
Publicado: (2017)

Novel Use of Hydroxyurea in an African Region With Malaria: Protocol for a Randomized Controlled Clinical Trial
por: Anyanwu, Juliana N, et al.
Publicado: (2016)

O047 An online sleep education workshop for trainee psychologists improves sleep knowledge, skills, and confidence to treat insomnia: A waitlist comparison study
por: Meaklim, H, et al.
Publicado: (2022)

It’s high time to turn the spotlight on HbSC disease
por: Oluwole, Olubusola, et al.
Publicado: (2023)

Evaluation of treatment patterns, healthcare resource utilization and cost of illness for sickle cell disease in Ghana: a private medical insurance claims database study
por: Marfo, Kwaku, et al.
Publicado: (2023)

PI-03: THE EFFECT OF HYDROXYUREA IN THE GUT MICROBIOME OF ANGOLAN CHILDREN WITH SICKLE CELL DISEASE
por: M., DELGADINHO, et al.
Publicado: (2022)

P-034: EFFECTS OF HYDROXYUREA ON SKELETAL MUSCLE MICROVASCULATURE OF MICE WITH SICKLE CELL DISEASE
por: M., RICCETTI, et al.
Publicado: (2022)

5595849 THE GUT MICROBIOME AND HYDROXYUREA EFFECT ON SICKLE CELL DISEASE CHILDREN FROM ANGOLA
por: Brito, M., et al.
Publicado: (2023)

P047 Slow Wave Dynamics in Mild Cognitive Impairment compared with Age Matched Controls: A High Density EEG study.
por: Chapman, J, et al.
Publicado: (2023)

OMIP‐047: High‐Dimensional phenotypic characterization of B cells
por: Liechti, Thomas, et al.
Publicado: (2018)

P-048: INFLUENCE OF SEVEN GENETIC POLYMORPHISMS ON THE RESPONSE TO SICKLE CELL DISEASE THERAPY WITH HYDROXYUREA
por: O., FRANCO SANTOS, et al.
Publicado: (2022)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

HbSC Disease and Spontaneous Epidural Hematoma with Kernohan's Notch Phenomena
por: Yogarajah, Meera, et al.
Publicado: (2015)

A study reaches maturity. 25 years of the HBSC study in Germany
por: Richter, Matthias
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_coq7jt4f9g60blnmkj3do86be1